SignatureFD’s Wave Life Sciences WVE Stock Holding History

SignatureFD’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.09K	Buy	1,917 +607	+46%	+$3.19K	﹤0.01%	2829
2026 Q2	$7.61K	Hold	1,310	–	–	﹤0.01%	2742
2026 Q1	$9.5K	Buy	1,310 +1,000	+323%	+$13K	﹤0.01%	2542
2025 Q4	$5.27K	Hold	310	–	–	﹤0.01%	2670
2025 Q3	$2.27K	Hold	310	–	–	﹤0.01%	2917
2025 Q2	$2.02K	Buy	+310	New	+$2.05K	﹤0.01%	2863
2023 Q2	–	Sell	-238	Closed	-$1.03K	–	3380
2023 Q1	$1.03K	Buy	238 +138	+138%	+$632	﹤0.01%	2987
2022 Q4	$700	Buy	+100	New	+$461	﹤0.01%	3051
2021 Q4	–	Sell	-293	Closed	-$1K	–	3294
2021 Q3	$1K	Sell	293 -182	-38%	-$1.1K	﹤0.01%	2950
2021 Q2	$3K	Buy	475 +186	+64%	+$1.22K	﹤0.01%	2500
2021 Q1	$2K	Buy	289 +227	+366%	+$2.18K	﹤0.01%	2544
2020 Q4	$0	Buy	+62	New	+$520	﹤0.01%	2725

Other funds holding WVE

GSK plc London $497M AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Pfizer New York $164M AUM 53.62% 1-Year Est. Return

SignatureFD's WVE Position: Q3 2026 in Review

SignatureFD increased its Wave Life Sciences (WVE) stake by 46% in Q3 2026, buying an estimated $3.19K and bringing the position to 1,917 shares worth $7.09K. The position accounts for ﹤0.01% of the portfolio, ranked #2829.

SignatureFD first reported a position in WVE in Q4 2020 and has held it in 12 quarters since. The position peaked at $9.5K in Q1 2026. 114 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

SignatureFD held 1,917 shares of Wave Life Sciences worth $7.09K as of Q3 2026.
SignatureFD bought 607 Wave Life Sciences shares in Q3 2026, an estimated $3.19K.
Wave Life Sciences made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2829 holding.
SignatureFD first reported a position in Wave Life Sciences in Q4 2020 and has held it in 12 quarters since.
SignatureFD's Wave Life Sciences position peaked at $9.5K in Q1 2026.
114 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.